Amicus Formulations India Private Limited

Amicus Formulations India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2014PTC096589 Incorporated 28 November 2014 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2023
₹1,200
▼ 96% YoY
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹7.76 Cr
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date
Last AGM
30 Sep 2024
Annual general meeting
Company status
Active
MCA master data

About Amicus Formulations India Private Limited

Data last updated:

Amicus Formulations India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 November 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC096589.

The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.76 Cr. It is led by directors Vamshider Joganpally Rao and Sushanth Yellapantula.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No:8 – 2 – 686/6/D/5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034.

Court records list 1 case involving the company, including 1 filed against it. The company has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genesysbiologics.com.

Company details

CIN U24232TG2014PTC096589
Registration Number 096589
Incorporation Date 28 November 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Amicus Formulations India Private Limited's registered office is in Hyderabad, Telangana. Its website is genesysbiologics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    H No:8 – 2 – 686/6/D/5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Amicus Formulations India Private Limited, buy the company report.

Comprehensive company report
Amicus Formulations India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Amicus Formulations India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Amicus Formulations India Private Limited, buy the company report.

Financials of Amicus Formulations India Private Limited

FY 2024 filings available

Amicus Formulations India Private Limited reported revenue of ₹1,200 (down 96% YoY) for FY 2023.

Revenue · FY 2023
₹1,200 ▼ 96%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 96%
5 years · compounded
▼ 74%

Revenue has declined at a compounded annual rate (CAGR) of 74% over five years, including a 96% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1,200
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Amicus Formulations India Private Limited, buy the company report.

Board of directors of Amicus Formulations India Private Limited

Amicus Formulations India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sushanth YellapantulaAdditional Director16 Apr 20242 Years 7 MonthsCurrent
Vamshider Joganpally RaoDirector28 Nov 201411 Years 11 MonthsCurrent

Auditor

Amicus Formulations India Private Limited is audited by Anant Rao & Mallik for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Anant Rao & MallikFY 2023006266S

Shareholding

The shareholding of Amicus Formulations India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Amicus Formulations India Private Limited, buy the company report.

Deals & funding

Amicus Formulations India Private Limited has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.

Total deals
29
Rights issues
23
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹5.1 Cr

Deals on record (5 of 29)

WhenDealAmountParties
Feb 2019Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Oct 2018Secondary share transferUndisclosedBuyer: 3 individuals
Seller: an individual
Sep 2017Rights issue₹4.92 CrInvestors: 4 individuals
Seller: 4 individuals
Jul 2017Rights issue₹1.14 CrInvestors: 3 individuals
Jun 2017Rights issue₹37 LakhInvestors: an individual

To see the full deal history of Amicus Formulations India Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Amicus Formulations India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Amicus Formulations India has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Associated companies

GST

No GST registration is on our record for Amicus Formulations India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Amicus Formulations India Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Krishna Yeachuri ceased to be Director on 17 Apr 2024.

AGM
Amicus Formulations India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Krishna Yeachuri ceased to be Director.
Appointed
Sushanth Yellapantula was appointed as Additional Director.
Filing
Amicus Formulations India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Rajender Juvvadi Rao ceased to be Director.
Appointed
Vamshider Joganpally Rao was appointed as Director.
Incorporation
28 Nov 2014
Amicus Formulations India Private Limited was registered on 28 Nov 2014 with Roc Hyderabad & aged 11 years 11 months as per MCA records.

Frequently asked questions

Amicus Formulations India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 November 2014 (12+ years old) and is registered under CIN U24232TG2014PTC096589.

Amicus Formulations India has 2 current directors:

The latest financial statements of Amicus Formulations India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Amicus Formulations India is U24232TG2014PTC096589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Amicus Formulations India has 1 court case on record: 1 filed against it.

Amicus Formulations India was incorporated on 28 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.

Amicus Formulations India has 29 deals on record (23 rights issues, 4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.1 Cr; the latest was in February 2019.

Krishna Yeachuri ceased to be Director on 17 Apr 2024. Sushanth Yellapantula was appointed as Additional Director on 16 Apr 2024. Rajender Juvvadi Rao ceased to be Director on 20 Nov 2020. Amicus Formulations India has 4 board changes on record in total.

Amicus Formulations India can be reached through the website genesysbiologics.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Amicus Formulations India is at H No:8 – 2 – 6866D5 Road No:12 Banjara Hills, Hyderabad, Telangana, India – 500034.